13F filing recap · Q2 2025

What did Elliott Investment Management buy in Q2 2025?

Reported stock-position changes between this filing and the previous one.

Stock value

$12.09B

Positions

Estimated turnover

15.9%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

Quarter in review

Elliott Investment Management opened new positions in Hewlett Packard Enterprise, iShares Trust, and Osisko Gold Royalties. It exited ARM Holdings, Biomarin Pharmaceutical, Cormedix, E2open Parent Holdings, HDFC Bank, Howmet Aerospace, Match Group, Osisko Gold Royalties, and Transocean. The firm also added to its Phillips 66 stake.

New positions

HPEHewlett Packard Enterprise Company$381.00Mreported value+18.63M shares HYGiShares Trust$306.47Mreported value+3.80M shares OROsisko Gold Royalties Ltd$56.05Mreported value+2.18M shares

Increased positions

PSXPhillips 66$2.30Breported value+3.53M shares+22.4%

Exited positions

BMRNBiomarin Pharmaceutical Inc$247.44Mprior reported value-3.50M shares-100.0%MTCHMatch Group, Inc.$187.20Mprior reported value-6.00M shares-100.0%ETWOE2open Parent Holdings Inc$54.50Mprior reported value-27.25M shares-100.0%OREUROsisko Gold Royalties Ltd$46.04Mprior reported value